Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

A transatlantic cooperation for enriched neuroscience training.

Witter MP, Karagogeos D, Van Bockstaele EJ, Segal RA.

Eur J Neurosci. 2018 Jul;48(2):1717-1719. doi: 10.1111/ejn.14056. Epub 2018 Jul 4. No abstract available.

PMID:
29938860
2.

Paclitaxel Reduces Axonal Bclw to Initiate IP3R1-Dependent Axon Degeneration.

Pease-Raissi SE, Pazyra-Murphy MF, Li Y, Wachter F, Fukuda Y, Fenstermacher SJ, Barclay LA, Bird GH, Walensky LD, Segal RA.

Neuron. 2017 Oct 11;96(2):373-386.e6. doi: 10.1016/j.neuron.2017.09.034.

3.

A Transposon Screen Identifies Loss of Primary Cilia as a Mechanism of Resistance to SMO Inhibitors.

Zhao X, Pak E, Ornell KJ, Pazyra-Murphy MF, MacKenzie EL, Chadwick EJ, Ponomaryov T, Kelleher JF, Segal RA.

Cancer Discov. 2017 Dec;7(12):1436-1449. doi: 10.1158/2159-8290.CD-17-0281. Epub 2017 Sep 18.

PMID:
28923910
4.

A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy.

Fukuda Y, Li Y, Segal RA.

Front Neurosci. 2017 Aug 31;11:481. doi: 10.3389/fnins.2017.00481. eCollection 2017. Review.

5.

A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas.

Sun Y, Alberta JA, Pilarz C, Calligaris D, Chadwick EJ, Ramkissoon SH, Ramkissoon LA, Garcia VM, Mazzola E, Goumnerova L, Kane M, Yao Z, Kieran MW, Ligon KL, Hahn WC, Garraway LA, Rosen N, Gray NS, Agar NY, Buhrlage SJ, Segal RA, Stiles CD.

Neuro Oncol. 2017 Jun 1;19(6):774-785. doi: 10.1093/neuonc/now261.

6.

Hedgehog Signal Transduction: Key Players, Oncogenic Drivers, and Cancer Therapy.

Pak E, Segal RA.

Dev Cell. 2016 Aug 22;38(4):333-44. doi: 10.1016/j.devcel.2016.07.026. Review.

7.

Tyrosine receptor kinase B is a drug target in astrocytomas.

Ni J, Xie S, Ramkissoon SH, Luu V, Sun Y, Bandopadhayay P, Beroukhim R, Roberts TM, Stiles CD, Segal RA, Ligon KL, Hahn WC, Zhao JJ.

Neuro Oncol. 2017 Jan;19(1):22-30. doi: 10.1093/neuonc/now139. Epub 2016 Jul 10.

8.

There and back again: coordinated transcription, translation and transport in axonal survival and regeneration.

Tasdemir-Yilmaz OE, Segal RA.

Curr Opin Neurobiol. 2016 Aug;39:62-8. doi: 10.1016/j.conb.2016.04.006. Epub 2016 Apr 28. Review.

9.

The RNA-binding protein SFPQ orchestrates an RNA regulon to promote axon viability.

Cosker KE, Fenstermacher SJ, Pazyra-Murphy MF, Elliott HL, Segal RA.

Nat Neurosci. 2016 May;19(5):690-696. doi: 10.1038/nn.4280. Epub 2016 Mar 28.

10.

Lessons from a bridge generation.

Segal RA.

Science. 2016 Mar 25;351(6280):1494. doi: 10.1126/science.351.6280.1494. No abstract available.

PMID:
27013735
11.

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies.

Chadwick EJ, Yang DP, Filbin MG, Mazzola E, Sun Y, Behar O, Pazyra-Murphy MF, Goumnerova L, Ligon KL, Stiles CD, Segal RA.

J Vis Exp. 2015 Nov 7;(105):e53304. doi: 10.3791/53304.

12.

Prolyl Isomerase Pin1 Regulates Axon Guidance by Stabilizing CRMP2A Selectively in Distal Axons.

Balastik M, Zhou XZ, Alberich-Jorda M, Weissova R, Žiak J, Pazyra-Murphy MF, Cosker KE, Machonova O, Kozmikova I, Chen CH, Pastorino L, Asara JM, Cole A, Sutherland C, Segal RA, Lu KP.

Cell Rep. 2015 Oct 27;13(4):812-828. doi: 10.1016/j.celrep.2015.09.026. Epub 2015 Oct 17.

13.

A Polyamine Twist on Hedgehog Signaling.

Zhao X, Segal RA.

Dev Cell. 2015 Oct 12;35(1):1-2. doi: 10.1016/j.devcel.2015.09.024.

14.

CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.

Zhou P, Erfani S, Liu Z, Jia C, Chen Y, Xu B, Deng X, Alfáro JE, Chen L, Napier D, Lu M, Huang JA, Liu C, Thibault O, Segal R, Zhou BP, Kyprianou N, Horbinski C, Yang XH.

Oncotarget. 2015 Oct 6;6(30):29675-93. doi: 10.18632/oncotarget.4896.

15.

How neuronal activity regulates glioma cell proliferation.

Filbin MG, Segal RA.

Neuro Oncol. 2015 Dec;17(12):1543-4. doi: 10.1093/neuonc/nov188. Epub 2015 Sep 10. No abstract available.

16.

RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.

Zhao X, Ponomaryov T, Ornell KJ, Zhou P, Dabral SK, Pak E, Li W, Atwood SX, Whitson RJ, Chang AL, Li J, Oro AE, Chan JA, Kelleher JF, Segal RA.

Cancer Res. 2015 Sep 1;75(17):3623-35. doi: 10.1158/0008-5472.CAN-14-2999-T. Epub 2015 Jun 30.

17.

Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.

Bergthold G, Bandopadhayay P, Hoshida Y, Ramkissoon S, Ramkissoon L, Rich B, Maire CL, Paolella BR, Schumacher SE, Tabak B, Ferrer-Luna R, Ozek M, Sav A, Santagata S, Wen PY, Goumnerova LC, Ligon AH, Stiles C, Segal R, Golub T, Grill J, Ligon KL, Chan JA, Kieran MW, Beroukhim R.

Neuro Oncol. 2015 Nov;17(11):1486-96. doi: 10.1093/neuonc/nov045. Epub 2015 Mar 29.

18.

The Eya1 phosphatase promotes Shh signaling during hindbrain development and oncogenesis.

Eisner A, Pazyra-Murphy MF, Durresi E, Zhou P, Zhao X, Chadwick EC, Xu PX, Hillman RT, Scott MP, Greenberg ME, Segal RA.

Dev Cell. 2015 Apr 6;33(1):22-35. doi: 10.1016/j.devcel.2015.01.033. Epub 2015 Mar 26.

19.

Preserve and protect: maintaining axons within functional circuits.

Pease SE, Segal RA.

Trends Neurosci. 2014 Oct;37(10):572-82. doi: 10.1016/j.tins.2014.07.007. Epub 2014 Aug 26. Review.

20.

Shh-proteoglycan interactions regulate maturation of olfactory glomerular circuitry.

Persson L, Witt RM, Galligan M, Greer PL, Eisner A, Pazyra-Murphy MF, Datta SR, Segal RA.

Dev Neurobiol. 2014 Dec;74(12):1255-67. doi: 10.1002/dneu.22202. Epub 2014 Jun 27.

Supplemental Content

Loading ...
Support Center